Transfersome is a trademark registered by the German company IDEA AG, which refers to its proprietary drug delivery technology, an artificial vesicle designed to exhibit the characteristics of a cell vesicle suitable for controlled and potentially targeted drug delivery. Some evidence has shown efficacy for its use for drug delivery without causing skin irritation, potentially being used to treat skin cancer.
- Gupta, Ankit; Aggarwal, Geeta; Singla, Samita; Arora, Ritika (August 31, 2012). "Transfersomes: A Novel Vesicular Carrier for Enhanced Transdermal Delivery of Sertraline: Development, Characterization, and Performance Evaluation". Sci Pharm. 80 (4): 1061–1080. doi:10.3797/scipharm.1208-02. PMC 3528046. PMID 23264950.
- Rai, Shubhra; Pandey, Vikas; Rai, Gopal (June 7, 2017). "Transfersomes as versatile and flexible nano-vesicular carriers in skin cancer therapy: the state of the art". Nano Rev Exp. 8 (1): 1325708. doi:10.1080/20022727.2017.1325708. PMC 6167026. PMID 30410704.